Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Rogers-Evans

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Organic Chemistry|September 11, 2004
Synthesis of 1,4-benzodiazepine-3,5-dionesPer Wiklund, Mark Rogers-Evans, Jan Bergman
Organic Letters|October 20, 2011
Synthesis of novel azaspiro[3.4]octanes as multifunctional modules in drug discoveryDong Bo Li, Mark Rogers-Evans, Erick M Carreira
Organic Letters|September 3, 2013
Construction of multifunctional modules for drug discovery: synthesis of novel thia/oxa-azaspiro[3.4]octanesDong Bo Li, Mark Rogers-Evans, Erick M Carreira
Organic Letters|April 23, 2004
A concise asymmetric route to the bridged bicyclic tropane alkaloid ferruginine using enyne ring-closing metathesisVarinder K Aggarwal, Christopher J Astle, Mark Rogers-Evans
Current Opinion in Chemical Biology|June 9, 2004
Ligand identification for G-protein-coupled receptors: a lead generation perspectiveKonrad H Bleicher, Luke G Green, Rainer E Martin, et al.
Angewandte Chemie (International Ed. in English)|October 30, 2010
Oxetanes as versatile elements in drug discovery and synthesisJohannes A Burkhard, Georg Wuitschik, Mark Rogers-Evans, et al.
Organic Letters|April 2, 2010
Synthesis and structural analysis of a new class of azaspiro[3.3]heptanes as building blocks for medicinal chemistryJohannes A Burkhard, Carine Guérot, Henner Knust, et al.
Organic Letters|August 14, 2013
Synthesis and stability of oxetane analogs of thalidomide and lenalidomideJohannes A Burkhard, Georg Wuitschik, Jean-Marc Plancher, et al.
Journal of Medicinal Chemistry|March 31, 2010
Oxetanes in drug discovery: structural and synthetic insightsGeorg Wuitschik, Erick M Carreira, Björn Wagner, et al.
Chimia|December 2, 2014
Adventures in drug-like chemistry space: from oxetanes to spiroazetidines and beyond!Mark Rogers-Evans, Henner Knust, Jean-Marc Plancher, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Organic Chemistry|September 11, 2004
Synthesis of 1,4-benzodiazepine-3,5-dionesPer Wiklund, Mark Rogers-Evans, Jan Bergman
Organic Letters|October 20, 2011
Synthesis of novel azaspiro[3.4]octanes as multifunctional modules in drug discoveryDong Bo Li, Mark Rogers-Evans, Erick M Carreira
Organic Letters|September 3, 2013
Construction of multifunctional modules for drug discovery: synthesis of novel thia/oxa-azaspiro[3.4]octanesDong Bo Li, Mark Rogers-Evans, Erick M Carreira
Organic Letters|April 23, 2004
A concise asymmetric route to the bridged bicyclic tropane alkaloid ferruginine using enyne ring-closing metathesisVarinder K Aggarwal, Christopher J Astle, Mark Rogers-Evans
Current Opinion in Chemical Biology|June 9, 2004
Ligand identification for G-protein-coupled receptors: a lead generation perspectiveKonrad H Bleicher, Luke G Green, Rainer E Martin, et al.
Angewandte Chemie (International Ed. in English)|October 30, 2010
Oxetanes as versatile elements in drug discovery and synthesisJohannes A Burkhard, Georg Wuitschik, Mark Rogers-Evans, et al.
Organic Letters|April 2, 2010
Synthesis and structural analysis of a new class of azaspiro[3.3]heptanes as building blocks for medicinal chemistryJohannes A Burkhard, Carine Guérot, Henner Knust, et al.
Organic Letters|August 14, 2013
Synthesis and stability of oxetane analogs of thalidomide and lenalidomideJohannes A Burkhard, Georg Wuitschik, Jean-Marc Plancher, et al.
Journal of Medicinal Chemistry|March 31, 2010
Oxetanes in drug discovery: structural and synthetic insightsGeorg Wuitschik, Erick M Carreira, Björn Wagner, et al.
Chimia|December 2, 2014
Adventures in drug-like chemistry space: from oxetanes to spiroazetidines and beyond!Mark Rogers-Evans, Henner Knust, Jean-Marc Plancher, et al.
Pageof 3